As many biotech investors noticed, shares of Affymax (NASDAQOTH:AFFY) exploded yesterday, up 54%, with an unheard of amount of trading volume. In this video, Motley Fool health-care analyst David Williamson unwinds some of the rumors that may have led to this stock's jump, and warns investors that taking a position in this stock right now isn't investing, it's gambling, and you may be betting on a very shaky horse.
The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
More from The Motley Fool
The Nasdaq's 5 Most Hated Stocks
The Nasdaq hasn't had a down month this year, but that's not stopping skeptics from piling onto these five companies.
3 Reasons Investors Are Scared of Biotech Stocks
There's more than one way to see monster drops.
5 of Last Week's Biggest Losers
These five companies went the wrong way this past week.